Zydus Lifesciences Ltd - Company Profile
Powered by
All the data and insights you need on Zydus Lifesciences Ltd in one report.
- Save hours of research time and resources with
our up-to-date Zydus Lifesciences Ltd Strategy Report
- Understand Zydus Lifesciences Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Zydus Lifesciences Ltd (Zydus Lifesciences) formerly Cadila Healthcare Ltd, is an integrated global healthcare provider. It discovers, develops, manufactures and commercializes various healthcare products. The company’s product portfolio includes active pharmaceutical ingredients (APIs), formulations, wellness and animal health products. Zydus Lifesciences products find application in the treatment of diseases in the therapeutic areas of gastrointestinal, cardiovascular, respiratory, pain management, cancer, inflammation, neurology, and women's health, among others. It conducts research to develop biologics, biosimilars, vaccines and new chemical entities. The company has manufacturing facilities in Gujarat, Goa, Maharashtra, Sikkim and Himachal Pradesh in India; Brazil and the US. It has presence in the US, Europe, South Africa, Japan, Brazil, and other emerging markets. Zydus Lifesciences is headquartered in Ahmedabad, Gujarat, India.
Zydus Lifesciences Ltd premium industry data and analytics
Products and Services
Products | Brands |
---|---|
Generic Biosimilars | OCID QRS |
Generics Drugs | ATEN |
Formulations | FALCIGO |
XYZ | XYZ |
XYZ | XYZ |
XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
Year | Event | Description |
---|---|---|
2024 | New Products/Services | In March, the company introduced Olaparib, a PARP inhibitor. |
2024 | Plans/Strategy | In January, the company announced its plans to invest INR 5,000 crore in Gujarat, India. |
2023 | Contracts/Agreements | In November, the company and Lupin Limited signed a licensing and supply agreement to co-market, Saroglitazar Mg for the treatment of Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steato Hepatitis in India. |
Competitor Comparison
Key Parameters | Zydus Lifesciences Ltd | Sun Pharmaceutical Industries Ltd | Dr. Reddy's Laboratories Ltd | Cipla Ltd | Lupin Ltd |
---|---|---|---|---|---|
Headquarters | India | India | India | India | India |
City | Ahmedabad | Mumbai | Hyderabad | Mumbai | Mumbai |
State/Province | Gujarat | Maharashtra | Telangana | Maharashtra | Maharashtra |
No. of Employees | 23,026 | 41,000 | 24,832 | 26,615 | 18,971 |
Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
Name | Position | Board | Since | Age |
---|---|---|---|---|
Pankaj R. Patel | Chairman | Executive Board | 2002 | 70 |
Sharvil P. Patel, Ph.D. | Director; Managing Director - Deputy | Executive Board | 2007 | 45 |
Ganesh N. Nayak | Director | Executive Board | 2020 | 68 |
Nitin D. Parekh | Chief Financial Officer | Senior Management | 2009 | - |
Punit Patel | Chief Executive Officer - Americas; President - Americas | Senior Management | 2023 | - |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward